Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kodiak Sciences (KOD) EBT (2017 - 2026)

Kodiak Sciences filings provide 10 years of EBT readings, the most recent being -$58.1 million for Q1 2026.

  • Quarterly EBT fell 1.16% to -$58.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$230.5 million through Mar 2026, down 21.04% year-over-year, with the annual reading at -$229.9 million for FY2025, 30.83% down from the prior year.
  • EBT hit -$58.1 million in Q1 2026 for Kodiak Sciences, down from -$56.7 million in the prior quarter.
  • Across five years, EBT topped out at -$42.7 million in Q1 2024 and bottomed at -$95.7 million in Q1 2022.
  • Average EBT over 5 years is -$62.3 million, with a median of -$58.1 million recorded in 2026.
  • The largest annual shift saw EBT plummeted 89.82% in 2022 before it skyrocketed 43.82% in 2024.
  • Kodiak Sciences' EBT stood at -$71.1 million in 2022, then grew by 16.29% to -$59.5 million in 2023, then increased by 25.94% to -$44.0 million in 2024, then dropped by 28.71% to -$56.7 million in 2025, then dropped by 2.54% to -$58.1 million in 2026.
  • Per Business Quant, the three most recent readings for KOD's EBT are -$58.1 million (Q1 2026), -$56.7 million (Q4 2025), and -$61.4 million (Q3 2025).